<HashMap><database>biostudies-literature</database><scores/><additional><submitter>Dong X</submitter><funding>Tianjin Health Traditional Chinese Medicine Research Project</funding><funding>Tianjin Health Research Project</funding><funding>National Natural Science Foundation of China</funding><pagination>205</pagination><full_dataset_link>https://www.ebi.ac.uk/biostudies/studies/S-EPMC12903243</full_dataset_link><repository>biostudies-literature</repository><omics_type>Unknown</omics_type><volume>24(1)</volume><pubmed_abstract>&lt;h4>Background&lt;/h4>Functional constipation (FC) is a prevalent gastrointestinal disorder marked by impaired intestinal motility, affecting millions worldwide and significantly diminishing quality of life. Current therapeutic strategies provide only transient symptom relief and fail to restore colonic motor function. This study aims to explore the causal role of gut microbiota in FC, focusing on the mechanisms by which Roseburia intestinalis (RI) and its metabolite inosine improve intestinal motility.&lt;h4>Methods&lt;/h4>To identify protective gut taxa, we first performed bidirectional Mendelian randomization (MR) integrated with 16S rRNA sequencing on fecal samples from 30 FC patients and 30 healthy controls. Loperamide-induced constipation mouse models evaluated RI gavage effects on motility i</pubmed_abstract><journal>Journal of translational medicine</journal><pubmed_title>Roseburia intestinalis-derived inosine improves intestinal motility by activating TGF-β1/p-Smad3/Transgelin signaling axis.</pubmed_title><pmcid>PMC12903243</pmcid><funding_grant_id>2025185</funding_grant_id><funding_grant_id>TJWJ2024XK004</funding_grant_id><funding_grant_id>82370545</funding_grant_id><funding_grant_id>8217032098</funding_grant_id><pubmed_authors>Liu H</pubmed_authors><pubmed_authors>Sun M</pubmed_authors><pubmed_authors>Jiang K</pubmed_authors><pubmed_authors>Ruan H</pubmed_authors><pubmed_authors>Dong X</pubmed_authors><pubmed_authors>Wang B</pubmed_authors><pubmed_authors>Chen M</pubmed_authors><pubmed_authors>Zhang H</pubmed_authors><pubmed_authors>Zhong W</pubmed_authors></additional><is_claimable>false</is_claimable><name>Roseburia intestinalis-derived inosine improves intestinal motility by activating TGF-β1/p-Smad3/Transgelin signaling axis.</name><description>&lt;h4>Background&lt;/h4>Functional constipation (FC) is a prevalent gastrointestinal disorder marked by impaired intestinal motility, affecting millions worldwide and significantly diminishing quality of life. Current therapeutic strategies provide only transient symptom relief and fail to restore colonic motor function. This study aims to explore the causal role of gut microbiota in FC, focusing on the mechanisms by which Roseburia intestinalis (RI) and its metabolite inosine improve intestinal motility.&lt;h4>Methods&lt;/h4>To identify protective gut taxa, we first performed bidirectional Mendelian randomization (MR) integrated with 16S rRNA sequencing on fecal samples from 30 FC patients and 30 healthy controls. Loperamide-induced constipation mouse models evaluated RI gavage effects on motility i</description><dates><release>2025-01-01T00:00:00Z</release><publication>2025 Dec</publication><modification>2026-07-15T15:34:48.467Z</modification><creation>2026-07-06T03:10:34.326Z</creation></dates><accession>S-EPMC12903243</accession><cross_references><pubmed>41422035</pubmed><doi>10.1186/s12967-025-07366-6</doi></cross_references></HashMap>